GramEye
Funding Series
Series A
Funding Amount
149,746
Healthcare/Medtech

About

GramEye provides the world’s first AI medical device employing AI and robotics technology to improve gram stains—a type of infectious disease test.

Milestone

In 2025, GramEye plans to update the current gram staining standard from four classifications to a single test that can classify over 20 categories, including bacterial species that are difficult to distinguish using traditional gram staining.
Visit Site
We're Here to Help
Have questions? Not sure where to start? Send us an email and let’s chat!
Email Us